Theranostics is moving fast and is awash with capital. Learning about a rival’s trial or target after the fact costs you the white-space. Theranostix tracks the pipeline by target and sponsor over time, with a European lens, so you read the field early.
With 30+ developers and a wave of acquisitions, the competitive picture shifts weekly. Assembling it by hand from registries and congresses is slow, partial and always a step behind — exactly when timing decides who owns a target.
By the time a competitor’s move surfaces through normal channels, the strategic window may already be closing.
Pipeline intelligence is scattered across registries, press and conferences, with no single European view by target.
Without a structured landscape, the gaps worth pursuing are easy to miss.
See who is developing what, against which molecular target, and where — across Europe.
Watch how the pipeline shifts so you spot acceleration, entrants and exits as they happen.
Identify targets, indications and geographies where activity is thin and opportunity is real.
Not sure which tier fits? We’ll scope it with you.
Contact salesA 30-minute walkthrough, tailored to you — or talk to sales about a license.
Book an intelligence walkthroughContact sales